Biblio

Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Lin C, He Y, Feng Q, Xu K, Chen Z, Tao B, Li X, Xia Z, Jiang H, Cai K. Self-renewal or quiescence? Orchestrating the fate of mesenchymal stem cells by matrix viscoelasticity via PI3K/Akt-CDK1 pathway. Biomaterials. 2021;279:121235.
Nalla LVineela, Kalia K, Khairnar A. Self-renewal signaling pathways in breast cancer stem cells. Int J Biochem Cell Biol. 2018.
Guo M, Wu J, Chen C, Wang X, Gong A, Guan W, Karvas RM, Wang K, Min M, Wang Y, et al. Self-renewing human naïve pluripotent stem cells dedifferentiate in 3D culture and form blastoids spontaneously. Nat Commun. 2024;15(1):668.
Ruiz-Argüelles GJ, Olivares-Gazca JCarlos, Olivares-Gazca M, León-Peña AA, Murrieta-Alvarez I, Cantero-Fortiz Y, Gomez-Cruz GBerenice, Ruiz-Argüelles A, Priesca-Marin M, Ruiz-Delgado GJ. Self-reported changes in the expanded disability status scale (EDSS) score in patients with multiple sclerosis after autologous stem cell transplants: real-world data from a single center. Clin Exp Immunol. 2019.
Rua-Fernandez J, Lovejoy CA, Mehta KPM, Paulin KA, Toudji YT, Giansanti C, Eichman BF, Cortez D. Self-reversal facilitates the resolution of HMCES DNA-protein crosslinks in cells. Cell Rep. 2023;42(11):113427.
Ghosh S, Wu V, Pernal S, Uskokovic V. Self-setting calcium phosphate cements with tunable antibiotic release rates for advanced antimicrobial applications. ACS Appl Mater Interfaces. 2016.
Martino EAntonia, Vigna E, Bruzzese A, Labanca C, Mendicino F, Lucia E, Olivito V, Zimbo A, Torricelli F, Neri A, et al. Selinexor in multiple myeloma. Expert Opin Pharmacother. 2024.
Kalakonda N, Maerevoet M, Cavallo F, Follows G, Goy A, Vermaat JSP, Casasnovas O, Hamad N, Zijlstra JM, Bakhshi S, et al. Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial. Lancet Haematol. 2020;7(7):e511-e522.
Jiang C-Z, Lin Q-S, Wu X-Y, Wang C-Y, Kang D-Z. Sellar Solitary Plasmacytoma Progressing to Multiple Myeloma: A Case Report and Literature Review. Medicine (Baltimore). 2014;93(11):e58.
Snyder J, Turner L. Selling stem cell 'treatments' as research: prospective customer perspectives from crowdfunding campaigns. Regen Med. 2018;13(4):375-384.
Kayabaş A. SEM observations on the vegetative plant parts of Acantholimon riyatguelii Yıldırım (Plumbaginaceae), a local endemic restricted to gypsum habitats. J Struct Biol. 2021:107830.
Yang J, Yen K, Mahony S. SEM: sized-based expectation maximization for characterizing nucleosome positions and subtypes. bioRxiv. 2023.
Wang W, Chen B, Yang J, Li Y, Ding H, Liu H, Yuan C. Sema3A Modified PDLSCs Exhibited Enhanced Osteogenic Capabilities and Stimulated Differentiation of Pre-Osteoblasts. Cell Biochem Biophys. 2023.
Zhang C, Zhu Y, Liu Y, Zhang X, Yue Q, Li L, Chen Y, Lu S, Teng Z. SEMA3B-AS1-inhibited osteogenic differentiation of human mesenchymal stem cells revealed by quantitative proteomics analysis. J Cell Physiol. 2018.
Hao J, Han X, Huang H, Yu X, Fang J, Zhao J, Prayson RA, Bao S, Yu JS. Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma. Nat Commun. 2023;14(1):2262.
Lu Q, Liu Z, Zhao L, Xu L, Liu C, Li L, Cao Y, Li F, Wu L, Wang L, et al. Sema7A protects against high-fat diet-induced obesity and hepatic steatosis by regulating adipo/lipogenesis. Mol Metab. 2023:101698.
Stafeev I, Agareva M, Michurina S, Tomilova A, Shestakova E, Zubkova E, Sineokaya M, Ratner E, Menshikov M, Parfyonova Y, et al. Semaglutide 6-months therapy of type 2 diabetes mellitus restores adipose progenitors potential to develop metabolically active adipocytes. Eur J Pharmacol. 2024:176476.
Sun Z, Yan K, Liu S, Yu X, Xu J, Liu J, Li S. Semaphorin 3A promotes the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells in inflammatory environments by suppressing the Wnt/β-catenin signaling pathway. J Mol Histol. 2021.
Jeon H-M, Shin YJae, Lee J, Chang N, Woo D-H, Lee WJun, Nguyen D, Kang W, Cho HJin, Yang H, et al. The Semaphorin 3A-Neuropilin-1 Pathway Promotes Clonogenic Growth of Glioblastoma via Activation of TGFβ Signaling. JCI Insight. 2023.
Gonçalves CE da Silva, Fock RA. Semaphorins and the bone marrow microenvironment: New candidates that influence the hematopoietic system. Cytokine Growth Factor Rev. 2024.
Fard D, Barbiera A, Dobrowolny G, Tamagnone L, Scicchitano BMaria. Semaphorins: Missing Signals in Age-dependent Alteration of Neuromuscular Junctions and Skeletal Muscle Regeneration. Aging Dis. 2023.
Li WN, Jia MM, Peng YQ, Ding R, Fan LQ, Liu G. Semen quality pattern and age threshold: a retrospective cross-sectional study of 71,623 infertile men in China, between 2011 and 2017. Reprod Biol Endocrinol. 2019;17(1):107.
Henn I, Atkins A, Markus A, Shpun G, Barad H-N, Farah N, Mandel Y. SEM/FIB Imaging for studying neural interfaces. Dev Neurobiol. 2019.
Gilda JE, Ko J-H, Elfassy A-Y, Tropp N, Parnis A, Ayalon B, Jhe W, Cohen S. A semi-automated measurement of muscle fiber size using the Imaris software. Am J Physiol Cell Physiol. 2021.
Hall J, Daniszewski M, Cheung S, Shobhana K, Kumar H, Liang HH, Beetham H, Cho E, Abbott C, Hewitt AW, et al. A Semi-Automated Pipeline for Quantifying Drusen-Like Deposits in Human Induced Pluripotent Stem Cell-Derived Retinal Pigmented Epithelial Cells. SLAS Technol. 2023.

Pages